Offer - Urjas Oil for just ₹ 1 X
Lopimune Tablet (60), a prescription drug, is manufactured in various forms such as Tablet. Lopimune Tablet (60) also has some secondary and off-label uses. These are listed below.
The optimal dosage of Lopimune Tablet (60) is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
The most common side effects of Lopimune Tablet (60) are Headache. Apart from the aforementioned side effects, Lopimune Tablet (60) can also lead to other problems, which have been listed below. Usually, these side effects of Lopimune Tablet (60) go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Lopimune Tablet (60)'s effect during pregnancy is Moderate and Moderate while nursing. In addition, Lopimune Tablet (60)'s effects on the liver, heart and kidney are discussed below in the Lopimune Tablet (60) related warnings section.
Lopimune Tablet (60) is contraindicated in people with pre-existing medical conditions like Liver Disease, Hemophilia as it can result in adverse effects. Some other conditions that can be affected by Lopimune Tablet (60) are listed in the contraindications section below.
Additionally, Lopimune Tablet (60) may also adversely react with other medicines. See below for a complete list.
In addition to the above precautions for Lopimune Tablet (60), it is important to know that it is not safe while driving, and is not habit-forming.
Lopimune Tablet (60) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Lopimune Tablet (60) safe for pregnant women?
Pregnant women may experience moderate side effects from Lopimune. It is best to stop taking Lopimune immediately and inform your doctor if you notice any discomfort.
Is the use of Lopimune Tablet (60) safe during breastfeeding?
Lopimune may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Lopimune, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Lopimune.
What is the effect of Lopimune Tablet (60) on the Kidneys?
Lopimune is not harmful for kidneys.
What is the effect of Lopimune Tablet (60) on the Liver?
Very few cases of side effects of Lopimune on the liver have been reported.
What is the effect of Lopimune Tablet (60) on the Heart?
Lopimune is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Lopimune Tablet (60) unless your doctor advises you to do so -
Is this Lopimune Tablet (60) habit forming or addictive?
Lopimune Tablet (60) is not addictive in nature.
Interaction between Food and Lopimune Tablet (60)
Some foods when eaten with Lopimune Tablet (60) can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Lopimune Tablet (60)
Taking alcohol with Lopimune Tablet (60) can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvir (ritonavir)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 810
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 939-941
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Kaletra (lopinavir and ritonavir)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 811